Author

W. J. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Animal Behavior & Cognition· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Organism:human· 4 Research Focus:cell type annotation· 3 Assay:bulk RNA-seq· 2 Organism:Drosophila· 2 Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Assay:whole-exome sequencing· 2

Frequent Co-Authors

A. L. Hong· 2 shared B. D. Kynnap· 2 shared C. M. Clinton· 2 shared D. E. Root· 2 shared E. A. Mullen· 2 shared J. S. Boehm· 2 shared K. L. Ligon· 2 shared P. C. Gokhale· 2 shared

Activity by Year

2018-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. L. Hong

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axis

A. Rao, X. Zhang, A. Cillo, J. H. Sussman, P. Sandlesh, A. C. Tarbay, A. N. Mallela, C. Cardello, K. Krueger, J. Xu, A. Li, J. Xu, J. Patterson, E. Akca, A. Angione, , N. M. Amankulor

This study shows that all-trans retinoic acid (ATRA) improves immune response in IDH-mutant gliomas by restoring the RA pathway, leading to tumor regression in mouse models and a clinical trial for human patients.

bioRxiv · Apr 9, 2024 · PreprintCancer Biology

Surface glia predominantly contribute to the development of ALS/FTD in Drosophila model

B. A. Snow, C. C. Stevenson, J. Kaur, S. G. Lee, Y. Wei, H. Miao, W. J. Kim

The paper shows surface glia are key in C9orf72-mediated ALS/FTD in Drosophila using genetic tools to mark glial subtypes.

bioRxiv · Oct 7, 2022 · PreprintPathology

Gut microbiota analysis of the western honeybee (Apis mellifera L.) infested with the mite Varroa destructor reveals altered bacterial and archaeal community

M. Kim, W. J. Kim, S.-J. Park

This study analyzes the gut microbiota of western honeybees infected with Varroa destructor, finding altered bacterial and archaeal communities in larvae and adult bees.

bioRxiv · Apr 20, 2022 · PreprintMicrobiology

Targeting TRIP13 in Wilms Tumor with Nuclear Export Inhibitors

K. Mittal, B. P. Lee, G. W. Cooper, J. Shim, H. C. Jonus, W. J. Kim, M. Doshi, D. Almanza, B. D. Kynnap, A. L. Christie, X. Yang, G. S. Cowley, B. A. Leeper, C. L. Morton, B. Dwivedi, , A. L. Hong

This study identifies XPO1 inhibition with selinexor as a potential therapy for favorable histology Wilms tumors, showing synergy with doxorubicin in preclinical models.

bioRxiv · Feb 23, 2022Cancer Biology

Neuropeptide relay between SIFa signaling controls the experience-dependent mating duration of male Drosophila

K. C. Wong, J. Schweizer, K.-N. H. Nguyen, S. Atieh, W. J. Kim

The paper identifies 7 neuropeptides in SIFa receptor-positive cells that regulate mating duration plasticity in male Drosophila through neuropeptide relay mechanisms.

bioRxiv · Oct 25, 2019 · PreprintAnimal Behavior & Cognition

Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition

A. L. Hong, Y.-Y. Tseng, J. A. Wala, W. J. Kim, B. D. Kynnap, M. B. Doshi, G. Kugener, G. J. Sandoval, T. P. Howard, J. Li, X. Yang, M. Tillgren, M. Ghandi, A. Sayeed, R. Deasy, , W. Hahn

This study identifies SMARCB1 loss as critical for RMC survival and shows proteasome inhibition as a potential therapeutic strategy.

bioRxiv · Dec 5, 2018Cancer Biology